infectious diseases

News

New COVID-19 jabs approved by FDA for 2024-25 season

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in r

News

Expert says supplies of mpox vaccine unlikely to suffice

Emergent BioSolutions, one of only three companies with a vaccine for mpox, has agreed to donate 50,000 doses of its shot for use in the current outbreak concentrated in central Africa, but

News

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight.

News

Colourised transmission electron micrograph of mpox virus particles (red/yellow) found within infected VERO E6 cells (brown)

As WHO calls mpox emergency, NIH says only drug ineffective

The only antiviral recognised as an mpox treatment was unable to shorten the time to resolution of lesions in a trial in the Democratic Republic of the Congo (DRC), the epicentre of an outb

News

Africa on high alert as mpox cases rise quickly

The rapid spread of a new variant of mpox – previously known as monkeypox – has prompted the Africa Centers for Disease Control and Prevention (Africa CDC) to declare a public health emerge

R&D

mRNA technologies: Looking beyond COVID vaccines

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications.

New COVID-19 jabs approved by FDA for 2024-25 season

Expert says supplies of mpox vaccine unlikely to suffice

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

As WHO calls mpox emergency, NIH says only drug ineffective

Africa on high alert as mpox cases rise quickly

mRNA technologies: Looking beyond COVID vaccines

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

infectious diseases

Editor's Picks